Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a reliable player in the pharmaceutical industry. The company’s primary segment is the manufacturing of APIs, which are the essential components of pharmaceutical drugs.
- Granules India Limited reported Total Income for Q4 FY23 of ₹1,198.87 Crore up from ₹1,033.93 Crore year on year, a growth of 16%.
- Total Expenses for Q4 FY23 of ₹1,034.89 Crore up from ₹883.81 Crore year on year, a growth of 17.1%.
- Consolidated Net Profit of ₹119.60 Crore, up 7.7% from ₹111 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹4.93, from ₹4.46 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,